| 영문 | rheumatoid factor | 한글 | 류마티스 인자 |
|---|---|---|---|
| 설명 | IgG의 Fc부위에 있는 항원결정인자에 대한 항체로서 전형적인 또는 확실한 류마티스관절염(rheumatoid arthritis) 환자의 80%에서 발견된다. 류마티스 인자는 IgM, IgG, IgA중 하나가 될 수 있으나 주로 IgM이다. 소아류마티스관절염(juvenile rheumatoid arthritis: 소아기에 발생하는 류마티스관절염)을 비롯한, 다른 결합조직병이나 감염병에도 나타날 수 있다 |
||
| 영문 | growth factor | 한글 | 성장인자 |
|---|---|---|---|
| 설명 | 세포의 분화 및 성장에 관여하는 단백질. 성장인자는 정상 세포주기에 필수적이기 때문에 동물의 생명에 중대한 요소가 된다. 무엇보다도 성장인자는 태아의 발육을 조정하고 조직의 유지 및 보수에 중대한 역할을 하며, 혈구의 생성을 자극한다. 또한 암의 진행과정에도 관여한다. |
||
| 영문 | risk factor | 한글 | 위험인자 |
|---|---|---|---|
| 설명 | 국제방사선방호위원회(ICRP)가 1977년 권고에서 방사선방호의 목적으로 채택한 지수로, 단위선량(1 Sv)당 확률적 영향의 발생확률을 추정하여 나타낸 것이다. 생식선 선량에 대한 유전적영향의 발생률(4×10－3/Sv)이나 적색골수선량에 대한 백혈병 발생률(2×10－3/Sv)등 외에 뼈, 허파, 갑상샘, 젖샘, 기타 조직의 위험지수를 측정하여, 확률적 영향의 전신에 있어서 치사위험지수의 합계를 16.5×10－3/Sv로 하였다. 그후 ICRP는 1990년 권고에서 대상이 되는 조직과 장기를 추가하고, 수치 개정을 하면서 명칭도 각목적확률지수라고하였다. 이 권고에 의하면, 치사적 확률적 영향의 확률지수의 합계는, 일반인에 있어 60.0×10－3/Sv이다. |
||
| CF | calcaneal fibular [ligament]; calcium leucovorin; calf blood flow; calibration factor; cancer-free; ... |
|---|---|
| EF | ectopic focus; edema factor; ejection fraction; elastic fibril; electric field; elongation factor; e... |
| PF | pair feeding; peak flow; perfusion fluid; pericardial fluid; periosteal fibroblast; peritoneal fluid... |
| PAF | paroxysmal atrial fibrillation; peroxisomal assembly factor; phosphodiesterase-activating factor; pl... |
| SF | Sabin-Feldman [test]; safety factor; salt-free; scarlet fever; screen film; seminal fluid; serosal f... |
| SRB | Sulfate Reducing Bacteria |
|---|---|
| SRB | Sulphate-reducing bacteria |
| D factor | Differentiation-stimulating factor |
| TRAF | Factor Receptor-associated factor |
| FVIII-vWF | Factor VIII-von Willebrand Factor |
IGF-II : insulin like growth factor-II의 약자. 많은 장기와 조직에 작용하여 단백 합성과 DNA, RNA의 합성을 증가시켜 세포의 수와 양을 증가
| reducing | From Reduce. <chemistry> Reducing furnace, a furnace for reducing ores. Reducing pipe fitting, a pipe fitting, as a coupling, an elbow, a tee, etc, for connecting a large pipe with a smaller one. Reducing valve, a device for automatically maintaining a diminished pressure of steam, air, gas, etc, in a pipe, or other receiver, which is fed from a boiler or pipe in which the pressure is higher than is desired in the receiver. Source: Websters Dictionary (01 Mar 1998) |
|---|---|
| reducing agent | A molecule that donates an electron in an oxidation-reduction reaction. (09 Oct 1997) |
| reducing agents | Materials that add an electron to an element or compound, that is, decrease the positiveness of its valence. (12 Dec 1998) |
| reducing diet | A diet in which caloric expenditure is greater than caloric intake. (05 Mar 2000) |
| reducing enzyme | <enzyme> An enzyme that catalyses a reduction; since all enzymes catalyze reactions in either direction, any reductase can, under the proper conditions, behave as an oxidase and vice versa, hence the term oxidoreductase. For individual reductase's, see the specific names. Synonym: reducing enzyme. (05 Mar 2000) |
| reducing sugar | A sugar, such as glucose in the urine, that has the property of reducing various inorganic ions, notably cupric ion to cuprous ion. (05 Mar 2000) |
| reducing valve | A valve designed to lower the pressure of a gas coming from a cylinder containing compressed gas under high pressure. (05 Mar 2000) |
| coenzyme F(420) reducing hydrogenase | <enzyme> From methanobacterium thermoautotrophicum Registry number: EC 1.12.- Synonym: f420-reducing hydrogenase, 8-hydroxy-5-deazaflavin-reducing hydrogenase, cof(420) reducing hydrogenase, coenzyme f420 hydrogenase (26 Jun 1999) |
| NADP-reducing hydrogenase | <enzyme> Operon from desulfovibrio contains 4 genes: hnda, hndb, hndc and hndd; does not reduce nad; genbank u07229 Registry number: EC 1.12.1.- Synonym: hnd gene product, hndabcd gene product (26 Jun 1999) |
| NAD(P)-reducing nickel hydrogenase | <enzyme> From cyanobacterium, synechocystis; genbank x97610 Registry number: EC 1.12.1.- (26 Jun 1999) |
| sulfur-reducing bacteria | A group of gram-negative, anaerobic bacteria that is able to oxidise acetate completely to carbon dioxide using elemental sulfur as the electron acceptor. (12 Dec 1998) |
| sulphate-reducing bacterium | <microbiology> A prokaryote which is able to reduce sulphate SO4 (as a terminal electron acceptor) using electrons donated from organic acids, fatty acids, alcohols or hydrogen (electron donors). (19 Jan 1998) |
| accelerator factor | <chemical> Heat- and storage-labile plasma glycoprotein which accelerates the conversion of prothrombin to thrombin in blood coagulation. Factor v accomplishes this by forming a complex with factor xa, phospholipid, and calcium (prothrombinase complex). Deficiency of factor v leads to owren's disease. Chemical name: Blood-coagulation factor V (12 Dec 1998) |
| acetate replacement factor | <biochemistry> 1,2 dithiolane 3 valeric acid. Regarded as a coenzyme in the oxoglutarate dehydrogenase complex of the citric acid cycle. Involved generally in oxidative decarboxylations of _ keto acids. A growth factor for some organisms. (18 Nov 1997) |
| adrenal weight factor | A postulated substance of adenohypophysial origin responsible for maintenance of the weight of the adrenal cortex. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|